{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:18:54Z","timestamp":1770970734755,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1016\/s0732-8893(99)00046-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:34:44Z","timestamp":1027618484000},"page":"19-25","source":"Crossref","is-referenced-by-count":185,"title":["International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents"],"prefix":"10.1016","volume":"35","author":[{"given":"M.A","family":"Pfaller","sequence":"first","affiliation":[]},{"given":"R.N","family":"Jones","sequence":"additional","affiliation":[]},{"given":"G.V","family":"Doern","sequence":"additional","affiliation":[]},{"given":"A.C","family":"Fluit","sequence":"additional","affiliation":[]},{"given":"J","family":"Verhoef","sequence":"additional","affiliation":[]},{"given":"H.S","family":"Sader","sequence":"additional","affiliation":[]},{"given":"S.A","family":"Messer","sequence":"additional","affiliation":[]},{"given":"A","family":"Houston","sequence":"additional","affiliation":[]},{"given":"S","family":"Coffman","sequence":"additional","affiliation":[]},{"given":"R.J","family":"Hollis","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0732-8893(99)00046-2_BIB1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogenous candidiasis caused by different Candida species","volume":"24","author":"Abi-Said","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB2","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.40.8.1948","article-title":"In vitro studies of two triazole antifungal agents (voriconazole [UK-109\u2013496] and fluconazole) against Candida species","volume":"40","author":"Barry","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1469-0691.1995.tb00456.x","article-title":"Fungemia","volume":"1","author":"Brunn","year":"1995","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/514504","article-title":"International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections","volume":"25","author":"Edwards","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/AAC.42.4.993","article-title":"In vitro activity of a new oral triazole, BMS-207147 (ER-30346)","volume":"42","author":"Fung-Tomc","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB6","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","article-title":"Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)","volume":"41","author":"Hajdu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0732-8893(98)00006-6","article-title":"Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and hands of health care workers","volume":"30","author":"Levin","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/AAC.42.1.161","article-title":"In vitro activities of voriconazole (UK-109\u2013496) and four other antifungal agents against 394 clinical isolates of Candida spp","volume":"42","author":"Marco","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0732-8893(98)00050-9","article-title":"Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp","volume":"31","author":"Marco","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB10","unstructured":"National Committee for Clinical Laboratory Standards (1997) Reference methods for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA."},{"key":"10.1016\/S0732-8893(99)00046-2_BIB11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The changing face of candidemia","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am J Med"},{"issue":"suppl 2","key":"10.1016\/S0732-8893(99)00046-2_BIB12","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/clinids\/22.Supplement_2.S89","article-title":"Nosocomial candidiasis","volume":"22","author":"Pfaller","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/AAC.41.2.233","article-title":"Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae","volume":"41","author":"Pfaller","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0732-8893(97)00192-2","article-title":"National surveillance of nosocomial blood stream infections due to species of Candida other than Candida albicans","volume":"30","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0732-8893(97)00245-9","article-title":"National Epidemiology of Mycoses Survey","volume":"31","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0732-8893(97)00240-X","article-title":"National surveillance of nosocomial blood stream infection due to Candida albicans","volume":"31","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB17","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/JCM.36.7.1886-1889.1998","article-title":"International surveillance of blood stream infections due to Candida species","volume":"36","author":"Pfaller","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AAC.41.3.575","article-title":"In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection","volume":"41","author":"Ruhnke","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","article-title":"Current and emerging azole antifungal agents","volume":"12","author":"Sheehan","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/BF01690507","article-title":"Occurrence of yeast blood stream infections between 1987 and 1995 in five Dutch University Hospitals","volume":"15","author":"Voss","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB22","series-title":"Manual of Clinical Microbiology","first-page":"723","article-title":"Candida, Cryptococcus, and other yeasts of medical importance","author":"Warren","year":"1995"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/clinids\/20.1.115","article-title":"Importance of Candida species other than C. albicans as pathogens in oncology patients","volume":"20","author":"Wingard","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0732-8893(99)00046-2_BIB26","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889399000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889399000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T16:42:06Z","timestamp":1579020126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889399000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["S0732889399000462"],"URL":"https:\/\/doi.org\/10.1016\/s0732-8893(99)00046-2","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}